Evidence map›Paper›PMID 42901940›Full record

ArticleNature communications2026

Structure of Blm10:13S proteasome intermediate reveals parallel assembly pathways for the proteasome core particle.

Mandeep Kaur, Xiang Chen, Stella Y Lee, Tyler M Weaver, Bret D Freudenthal, Kylie J Walters, Jeroen Roelofs

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mandeep Kaur *Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., HLSIC 1077, Kansas City, KS, USA.
Xiang Chen *Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.ORCID 0000-0002-0036-0212
Stella Y LeeDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., HLSIC 1077, Kansas City, KS, USA.
Tyler M WeaverDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., HLSIC 1077, Kansas City, KS, USA.ORCID 0000-0002-5138-7140
Bret D FreudenthalDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., HLSIC 1077, Kansas City, KS, USA.ORCID 0000-0003-1449-4710
Kylie J WaltersProtein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. kylie.walters@nih.gov.ORCID 0000-0001-7590-2891
Jeroen RoelofsDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., HLSIC 1077, Kansas City, KS, USA. jroelofs@kumc.edu.ORCID 0000-0003-0944-2465

Funding

Ubiquitin signaling for protein degradationZIABC011490 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WALTERS, KYLIE · 2013 to 2025
$21.1M
Supplement to NIH Award 2 R35GM128562-06R35GM128562 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Bret D Freudenthal · 2018 to 2026
$4.2M
Cryo-EM for the Midwest RegionS10OD036339 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FREUDENTHAL, BRET D · 2024 to 2024
$2.0M
NIGMS NIH HHS R35 GM128562NIH HHS S10 OD036339U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) ZIA BC011490U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35-GM128562U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35-GM149314U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) S10OD036339
6 · The paper itself

Abstract

The proteasome core particle (CP) can be capped by Blm10/PA200, which promotes ATP-independent degradation of disordered proteins and contributes to attenuating antigenic diversity and impacts immunotherapy upon upregulation. The assembly process that leads to Blm10-CP proteasomes remains unresolved and Blm10 is present not only at mature proteasomes but also bound to assembly intermediates. We identified and solved structures of five CP intermediate complexes by cryo-electron microscopy, two of which include Blm10. We find that CP intermediates interactions with Blm10 and Pba1/Pba2 chaperone complex are mutually exclusive and both leads to mature CP production. We further find no synergy between Pba1/Pba2 and Blm10 for CP assembly. These data suggest a parallel assembly pathway exists for Blm10 proteasomes that does not require sequential activity with Pba1/Pba2. Whereas CP affinity for Pba1/Pba2 is reduced during maturation to promote its release, no such affinity switch occurs for Blm10, further suggesting a parallel Blm10-assembly pathway for production of mature Blm10-bound CPs. Altogether, our findings reveal a functionally distinct CP assembly pathway for the production of mature Blm10-CP proteasomes.

Indexed as

Proteasome Endopeptidase ComplexCryoelectron MicroscopyModels, MolecularMolecular ChaperonesProtein BindingSaccharomyces cerevisiae ProteinsBlm10 protein, S cerevisiaeMolecular ChaperonesProteasome Endopeptidase ComplexSaccharomyces cerevisiae Proteins

Identifiers

PMID42901940
PMCPMC13683372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.